Skip to main content
. 2020 Oct 11;479(1):195–202. doi: 10.1007/s00428-020-02940-3

Table 2.

Immunohistochemical and molecular findings of all four cases

Case Immunohistochemistry Molecular testing
Melan A HMB-45 ALK, ROS, NTRK BRAF (V600E) p16 p21 Proliferation fraction BAP1 TCP MAP2K1 mutation - allele frequency CNVs
1 Positive Weakly positive superficially Negative - Few positive cells (checkerboard pattern) Positive Low (around 2%) Positive 30–50% c.306_311del (p.Ile103_Lys104del) - 13% 4a

Partial loss 2p

Partial loss and partial CN-LOH 19p

Chromothripsis 22q

2 Positive Positive (slightly less staining deeper) Negative Negative Negative (in majority of cells) Positive (mainly at junction) Low Positive 30% c.307_312del (p.Ile103_Lys104del) - 24% 6

Monosomy 9

Gain 6p

Partial loss 6q

Monosomy 10, 12, 19

3 Positive Positive (partly maintained deeper) Negative - Positive (checkerboard pattern) Negative - - 10–20% c.169A>G (p.Lys57Glu) - 7% 0 Probably not reliable due to low TCP
4 Positive Negative Negative - Focally positive Positive Very low - 60% c.306_311del (p.Ile103_Lys104del) - 28% 6 Trisomy chromosomes 5, 6, 11, 14, 15, and 20b

aChromothripsis of chromosome 22 was counted as 1 CNV

bDue to poor quality of the SNP array, presence of other CNVs could not be excluded completely

CN-LOH, copy neutral loss of heterozygosity; CNVs, copy number variations; TCP, tumor cell percentage